Pacific Biosciences Of California (PACB) Debt Ratio (2010 - 2023)

Pacific Biosciences Of California's Debt Ratio history runs 13 years deep, the most recent figure standing at 0.0 for Q4 2023.

• On a quarterly basis, Debt Ratio fell 99.71% year-over-year to 0.0 in Q4 2023; TTM through Dec 2023 was 0.0, a 99.71% decrease from a year earlier, with the FY2023 full-year figure at 0.0, down 99.71% from the prior year.
• Debt Ratio slipped to 0.0 in Q4 2023 per PACB's latest filing, from 0.05 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.35 in Q2 2023 and bottomed at 0.0 in Q4 2023.
• The 4-year median for Debt Ratio is 0.1 (2023), against an average of 0.1.
• Across the five-year window, Debt Ratio surged 4968.28% in 2022 and sank 99.71% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.11 in 2019, then slumped by 98.18% to 0.0 in 2021, then jumped by 4968.28% to 0.1 in 2022, then sank by 99.71% to 0.0 in 2023.
• Per Business Quant, the three latest PACB Debt Ratio figures stand at 0.0 (Q4 2023), 0.05 (Q3 2023), and 0.35 (Q2 2023).